Urine levels of transforming growth factor-beta 1 in children with ureteropelvic junction obstruction

Urology

Volumn 50, Issue 5, 1997, Pages 769-773

  Palmer, Lane S ^a,b   Maizels, Max ^a   Kaplan, William E ^a   Firlit, Casimir F ^a   Cheng, Earl Y ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CHILD; CIRCUMCISION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MALE; ORCHIDOPEXY; PRIORITY JOURNAL; PYELOPLASTY; URETER REIMPLANTATION; URETEROPELVIC JUNCTION OBSTRUCTION; URINALYSIS; VESICOURETERAL REFLUX;

BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYDRONEPHROSIS; INFANT; KIDNEY PELVIS; MALE; TRANSFORMING GROWTH FACTOR BETA; URETERAL OBSTRUCTION; VESICO-URETERAL REFLUX;

EID: 0030722492     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00331-2     Document Type: Article

References (22)

1. Rossi P, Karsenty G, Roberts AB, Roche NS, Sporn MB, and de Crombrugghe B: A nuclear factor 1 binding site mediates the transcriptional activation of a type 1 collagen promoter by transforming growth factor-beta. Cell 52: 405-414, 1988.
2. Edwards DR, Murphy G, Reynolds JJ, Whitman SE, Docherty AJ, Angel P, and Heath JK: Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6: 1899-1904, 1987.
3. Kagami S, Border WA, Ruoslahti E, and Noble NA: Coordinated expression of beta 1 integrins and transforming growth factor-beta-induced matrix proteins in glomerulonephritis. Lab Invest 69: 68-76, 1993.
4. Okuda S, Languino LR, Ruoslahti E, and Border WA: Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 86: 453-462, 1990.
5. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi YU, Pierschbacher MD, and Ruoslahti E: Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360: 361-364, 1992.
6. Seremitis GM, and Maizels M: TGF-beta mRNA expression in the renal pelvis after experimental and clinical ureteropelvic junction obstruction. J Urol 156: 261-266, 1996.
7. Chung KH, Gomez RA, and Chevalier RL: Regulation of renal growth factors and clusterin by AT1 receptors during neonatal ureteral obstruction. Am J Physiol 268(6 Pt 2): F1117-F1123, 1995.
8. Wright EJ, Robertson AP, Vaughan ED Jr, and Felsen D: Characterization of extracellular matrix, transforming growth factor-beta and interstitial macrophages in acute and chronic ureteral obstruction. J Urol 153: 264A, 1995.
9. Walton G, Buttyan R, Garcia-Montes E, Olsson CA, Hensle TW, and Sawczuk IS: Renal growth factor expression during the early phase of experimental hydronephrosis. J Urol 148(2 Pt 2): 510-514, 1992.
10. Kaneto H, Morrissey J, and Klahr S: Increased expression of TGF-beta1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 44: 313-321, 1993.
11. Conway JJ: "Well tempered" diuretic renography: its historical development, physiological and technical pitfalls, and standard technique protocol. Sem Nucl Med 22: 74-84, 1992.
12. Carr MC, Peters CA, Retik AB, and Mandell J: Urinary levels of renal tubular enzyme N-acetyl-β-D-glucosaminidase in relation to grade of vesicoureteral reflux. J Urol 146: 654-656, 1991.
13. Carr MC, Peters CA, Retik AB, and Mandell J: Urinary levels of renal tubular enzyme N-acetyl-beta-D-glucosaminidase in unilateral obstructive uropathy. J Urol 151: 442-445, 1994.
14. Williams MA, Jones D, and Noe HN: Urinary N-acetyl-beta-glucosaminidase as a screening technique for vesicoureteral reflux. Urology 43: 528-530, 1994.
15. Starr NT, Maizels M, Chou P, Brannigan R, and Shapiro E: Microanatomy and morphometry of the hydronephrotic "obstructed" renal pelvis in asymptomatic infants. J Urol 148(2 Pt 2): 519-524, 1992.
16. Roberts AB, Flanders KC, Kondaiah P, Thompson NL, Van Obberghen-Schilling E, Wakefield L, Rossi P, de Crombugghe B, Heine U, and Sporn MB: Transforming growth factor-beta: biochemistry and roles in embryogenesis, tissue repair and remodeling, and carcinogenesis. Recent Prog Horm Res 44: 157-197, 1988.
17. Sporn MB, and Roberts AB: Transforming growth factor-beta: recent progress and new challenges. J Cell Biol 119: 1017-1021, 1992.
18. Noh JW, Wiggins R, and Phan SH: Urine transforming growth factor-beta activity is related to the degree of scarring in crescentic nephritis in the rabbit. Nephron 63: 73-78, 1993.
19. Newcom SR, and Tagra KK: High molecular weight transforming growth factor beta is excreted in the urine in active nodular sclerosing Hodgkin's disease. Cancer Res 52: 6768-6773, 1992.
20. Kanai H, Mitsuhashi H, Ono K, Yano S, and Naruse T: Increased excretion of urinary transforming growth factor beta in patients with focal glomerular sclerosis. Nephron 66: 391-395, 1994.
21. Eder IE, Stenzl A, Hobisch A, Cronquer MV, Bartsch G, and Klocker H: Transforming growth factor-β types 1 and 2 in serum and urine from patients with bladder carcinoma. J Urol 156: 953, 1996.
22. Diamond JR, Kees-Folts D, Ding G, Frye JE, and Restrepo NC: Macrophages, monocyte chemoattractant peptide-1, and TGF-beta 1 in experimental hydronephrosis. Am J Physiol 266(6 Pt 2): F926-F933, 1994.